Delcath Systems (DCTH) Cash & Current Investments (2010 - 2026)
Delcath Systems' (DCTH) quarterly Cash & Current Investments came in at $89.3 million in Q1 2026, up 51.62% year-on-year from $58.9 million in Q1 2025, and down 1.91% quarter-over-quarter from $91.0 million in Q4 2025.
Delcath Systems (DCTH) Cash & Current Investments (2010 - 2026) Analysis & Trends
Delcath Systems' Cash & Current Investments history runs 17 years deep, the most recent figure standing at $89.3 million for Q1 2026.
- On a quarterly basis, Cash & Current Investments rose 51.62% year-over-year to $89.3 million in Q1 2026; TTM through Mar 2026 was $89.3 million, a 51.62% increase from a year earlier, with the FY2025 full-year figure at $91.0 million, up 71.01% from the prior year.
- Cash & Current Investments fell to $89.3 million in Q1 2026 per DCTH's latest filing, from $91.0 million in the prior quarter.
- Across five years, Cash & Current Investments topped out at $91.0 million in Q4 2025 and bottomed at $50000.0 in Q2 2023.
- The 5-year median for Cash & Current Investments is $19.8 million (2023), against an average of $35.9 million.
- Across the five-year window, Cash & Current Investments slumped 99.51% in 2023 and soared 10100.0% in 2024, its largest moves.
- Year by year, Cash & Current Investments stood at $4.2 million in 2022, then jumped by 378.2% to $19.8 million in 2023, then jumped by 168.18% to $53.2 million in 2024, then soared by 71.01% to $91.0 million in 2025, then retreated by 1.91% to $89.3 million in 2026.
- Per Business Quant, the three latest DCTH Cash & Current Investments figures stand at $89.3 million (Q1 2026), $91.0 million (Q4 2025), and $88.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 7.30 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 3.67 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 1.12 Bn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 2.29 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | 577.00 Mn |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 3.12 Bn |
| 10 | Delcath Systems | 432.25 Mn | 342.96 Mn | 21.26 Mn | 89.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 89.30 Mn |
| Dec 31, 2025 | 91.04 Mn |
| Sep 30, 2025 | 88.91 Mn |
| Jun 30, 2025 | 81.02 Mn |
| Mar 31, 2025 | 58.90 Mn |
| Dec 31, 2024 | 53.23 Mn |
| Sep 30, 2024 | 13.99 Mn |
| Jun 30, 2024 | 5.10 Mn |
| Mar 31, 2024 | 15.41 Mn |
| Dec 31, 2023 | 19.85 Mn |
| Sep 30, 2023 | 40.46 Mn |
| Jun 30, 2023 | 50,000.00 |
| Mar 31, 2023 | 24.22 Mn |
| Dec 31, 2022 | 4.15 Mn |
| Sep 30, 2022 | 9.83 Mn |
| Jun 30, 2022 | 10.20 Mn |
| Mar 31, 2022 | 4.15 Mn |
| Dec 31, 2021 | 22.80 Mn |
| Sep 30, 2021 | 4.15 Mn |
| Jun 30, 2021 | 151,000.00 |